Fact CheckerSign in

NCT07898592Not yet recruiting

Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance

Project EMPOWER-Neuro Developmental Disabilities (ND): Single Session Support for Parents of Children Struggling With Anxious Avoidance

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

This study will inform the development of a brief online program to help parents better understand and respond to anxiety-related behaviors in children with neurodevelopmental disorders (NDDs) such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), intellectual disability, and learning disorders). Many neurodiverse children experience high levels of anxiety, which can appear as avoidance, emotional distress, or challenging behaviors that are difficult for parents to interpret and manage. The purpose of this research is to evaluate EMPOWER-ND with its digital, single-session intervention (SSI) that provides practical parenting strategies for addressing anxiety-related behaviors in neurodiverse children. Parents of eligible children aged 5-14 with neurodevelopmental conditions will be invited to enroll in the research study.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
20 Oct 2026
Start date
Nov 2026
Primary completion date
Dec 2027
Lead sponsor
Boston University Charles River Campus
Diseases
Autism
NCT number
NCT07898592

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From Nov 2026 to the primary completion date, Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • If any of the inclusion criteria are not met

Who the study is looking for

  • Adult parent or primary caregiver of a child between the ages of 5-14 years.
  • The child has a clinical diagnosis of a neurodevelopmental disorder, such as autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), or a related neurodevelopmental condition.
  • Resides in the United States.
  • Able to read and understand English, as the survey and study materials are provided in English.
  • Has reliable internet connectivity and access to a device that can accommodate videoconferencing

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Boston University (Charles River Campus)
Coordinator of this site? Confirm its status
BostonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.